Annual Meeting of the Androgen Excess Society

雄激素过多协会年会

基本信息

项目摘要

DESCRIPTION (provided by applicant): The Annual Meeting of the Androgen Excess - Polycystic Ovary Syndrome (AE-PCOS) Society will be held in conjunction with the Annual Meeting of the American Society of Reproductive Medicine in 2013. The Annual Meeting of AE-PCOS convenes the world's largest group of researchers and clinicians in the area of androgen-related disorders. The annual gathering brings together participants to discuss their latest research findings, to encourage future research collaborations and to disseminate relevant and accurate health information to the clinical community and general public through worldwide press releases. The one and a half day meeting consists of multiple sessions that include lectures, slide and poster presentations, meet the professor sessions, all with interactive and/or question and answer opportunity. We have travel awards for junior investigators and propose to double those and add child care awards in this application to encourage the participation of the next generation of researchers and clinicians. We have demonstrated participation by females and minorities. The Society is composed of basic and clinical scientists and clinicians whose major interest is the etiology, diagnosis, and treatment of androgen excess disorders. Minority groups and genders are represented in the society's membership and governing boards. The AE-PCOS Annual Meeting rotates among the ASRM, The Endocrine Society and one international location every three years.
简介(由申请人提供):雄激素过量-多囊卵巢综合征(AE-PCOS)学会年会将于2013年美国生殖医学学会年会同时召开。AE-PCOS年会召集了世界上雄激素相关疾病领域最大的研究人员和临床医生。一年一度的会议将与会者聚集在一起,讨论他们的最新研究成果,鼓励未来的研究合作,并通过全球新闻稿向临床界和公众传播相关和准确的卫生信息。为期一天半的会议包括多个会议,包括讲座,幻灯片和海报展示,与教授会面,所有会议都有互动和/或问答机会。我们为初级研究人员提供旅行奖励,并建议将这些奖励加倍,并在此应用程序中添加儿童保育奖励,以鼓励下一代研究人员和临床医生的参与。我们已经证明了女性和少数民族的参与。该学会由基础和临床科学家和临床医生组成,他们的主要兴趣是雄激素过量疾病的病因、诊断和治疗。少数群体和性别在该协会的成员和管理委员会中都有代表。AE-PCOS年会每三年在ASRM,内分泌学会和一个国际地点轮流举行。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RICHARD S. LEGRO其他文献

RICHARD S. LEGRO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RICHARD S. LEGRO', 18)}}的其他基金

Early Intervention to Promote Cardiovascular Health of Mothers and Children in Northern Appalachia
早期干预促进阿巴拉契亚北部母亲和儿童的心血管健康
  • 批准号:
    10426872
  • 财政年份:
    2022
  • 资助金额:
    $ 0.6万
  • 项目类别:
Early Intervention to Promote Cardiovascular Health of Mothers and Children in Northern Appalachia
早期干预促进阿巴拉契亚北部母亲和儿童的心血管健康
  • 批准号:
    10618362
  • 财政年份:
    2022
  • 资助金额:
    $ 0.6万
  • 项目类别:
Inositol Supplementation to Treat Reproductive and Metabolic Dysfunction in Polycystic Ovary Syndrome: A Double Blind RCT (INSUPP-PCOS)
补充肌醇治疗多囊卵巢综合征的生殖和代谢功能障碍:双盲随机对照试验 (INSUPP-PCOS)
  • 批准号:
    9770795
  • 财政年份:
    2018
  • 资助金额:
    $ 0.6万
  • 项目类别:
Inositol Supplementation to Treat Reproductive and Metabolic Dysfunction in Polycystic Ovary Syndrome: A Double Blind RCT (INSUPP-PCOS)
补充肌醇治疗多囊卵巢综合征的生殖和代谢功能障碍:双盲随机对照试验 (INSUPP-PCOS)
  • 批准号:
    10475570
  • 财政年份:
    2018
  • 资助金额:
    $ 0.6万
  • 项目类别:
Inositol Supplementation to Treat Reproductive and Metabolic Dysfunction in Polycystic Ovary Syndrome: A Double Blind RCT (INSUPP-PCOS)
补充肌醇治疗多囊卵巢综合征的生殖和代谢功能障碍:双盲随机对照试验 (INSUPP-PCOS)
  • 批准号:
    10005132
  • 财政年份:
    2018
  • 资助金额:
    $ 0.6万
  • 项目类别:
Annual Meeting of the Androgen Excess Society
雄激素过多协会年会
  • 批准号:
    8895783
  • 财政年份:
    2013
  • 资助金额:
    $ 0.6万
  • 项目类别:
Annual Meeting of the Androgen Excess Society
雄激素过多协会年会
  • 批准号:
    8731146
  • 财政年份:
    2013
  • 资助金额:
    $ 0.6万
  • 项目类别:
PREGNANCY IN POLYCYSTIC OVARY SYNDROME II
多囊卵巢综合症 II 的妊娠
  • 批准号:
    7951306
  • 财政年份:
    2009
  • 资助金额:
    $ 0.6万
  • 项目类别:
CONTINUOUS GLUCOSE MONITORING IN PREGNANT WOMEN WITH POLYCYSTIC OVARY SYNDROME
多囊卵巢综合征孕妇的连续血糖监测
  • 批准号:
    7951242
  • 财政年份:
    2009
  • 资助金额:
    $ 0.6万
  • 项目类别:
24HR BLOOD PRESSURE MONITORING IN PATIENTS AT RISK FOR HYPERTENSION IN PREGNANCY
对妊娠期高血压风险患者进行 24 小时血压监测
  • 批准号:
    7951275
  • 财政年份:
    2009
  • 资助金额:
    $ 0.6万
  • 项目类别:

相似海外基金

Metagenomic discovery and optimization of novel endolysins targeting Cutibacterium acnes to treat acne vulgaris
针对痤疮皮肤杆菌治疗寻常痤疮的新型内溶素的宏基因组发现和优化
  • 批准号:
    10821291
  • 财政年份:
    2023
  • 资助金额:
    $ 0.6万
  • 项目类别:
Selective CYP26 inhibitors for the oral treatment of recalcitrant nodular acne.
用于口服治疗顽固性结节性痤疮的选择性 CYP26 抑制剂。
  • 批准号:
    10822482
  • 财政年份:
    2023
  • 资助金额:
    $ 0.6万
  • 项目类别:
Developing a novel medical-grade microneedle patch to treat acne vulgaris
开发一种新型医用级微针贴片来治疗寻常痤疮
  • 批准号:
    10053162
  • 财政年份:
    2023
  • 资助金额:
    $ 0.6万
  • 项目类别:
    Collaborative R&D
ENLIGHT : Light-sensitive Engineered Living Material for acne therapy
ENLIGHT:用于痤疮治疗的光敏工程活性材料
  • 批准号:
    EP/Y03029X/1
  • 财政年份:
    2023
  • 资助金额:
    $ 0.6万
  • 项目类别:
    Fellowship
Smart Photodynamic Therapy for Acne by Reversibly Switchable Intersystem Crossing in Pure Organic Materials
通过纯有机材料中的可逆可切换系间交叉来治疗痤疮的智能光动力疗法
  • 批准号:
    10483461
  • 财政年份:
    2022
  • 资助金额:
    $ 0.6万
  • 项目类别:
Th17 extracellular trap-mediated antimicrobial host defense in acne vulgaris
寻常痤疮中 Th17 细胞外陷阱介导的抗菌宿主防御
  • 批准号:
    10502200
  • 财政年份:
    2022
  • 资助金额:
    $ 0.6万
  • 项目类别:
Th17 extracellular trap-mediated antimicrobial host defense in acne vulgaris
寻常痤疮中 Th17 细胞外陷阱介导的抗菌宿主防御
  • 批准号:
    10698121
  • 财政年份:
    2022
  • 资助金额:
    $ 0.6万
  • 项目类别:
Acne: a disease of lipid metabolism, microbiome and the immune response
痤疮:一种脂质代谢、微生物组和免疫反应疾病
  • 批准号:
    10404440
  • 财政年份:
    2022
  • 资助金额:
    $ 0.6万
  • 项目类别:
Acne: a disease of lipid metabolism, microbiome and the immune response
痤疮:一种脂质代谢、微生物组和免疫反应疾病
  • 批准号:
    10404436
  • 财政年份:
    2022
  • 资助金额:
    $ 0.6万
  • 项目类别:
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
螺内酯与盐酸强力霉素治疗女性痤疮的随机、双盲、多中心比较疗效研究
  • 批准号:
    10296086
  • 财政年份:
    2021
  • 资助金额:
    $ 0.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了